EMEA-000990-PIP02-10

Active substance

Decision number

P/82/2011

Pharmaceutical form(s)

Route(s) of administration

Nasal use

Decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Compliance opinion date

24/06/2011

Active substance	Azelastine (hydrochloride) fluticasone propionate
Therapeutic area	Pneumology-allergology
Decision number	P/82/2011
PIP number	EMEA-000990-PIP02-10
Pharmaceutical form(s)	Nasal spray suspension
Condition(s) / indication(s)	Treatment of allergic rhinitis Treatment of rhino-conjuctivitis
Route(s) of administration	Nasal use
Contact for public enquiries	MEDA Pharma GmbH & Co. KG info@medapharma.de Germany Phone +49 617288801 Fax +49 61728881112
Decision type	P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance procedure number	EMEA-C-000990-PIP02-10
Compliance opinion date	24/06/2011
Compliance outcome	positive